Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
98.24
USD
+1.32 (+1.36%)
Official Closing Price
Updated: 7:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,445,600
Open
95.76
Bid (Size)
97.50 (4)
Ask (Size)
97.90 (1)
Prev. Close
96.92
Today's Range
95.45 - 98.79
52wk Range
78.06 - 181.83
Shares Outstanding
65,531,046
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
January 13, 2021
From
GlobeNewswire News Releases
Sarepta Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
January 12, 2021
From
GlobeNewswire News Releases
Performance
YTD
-40.57%
-40.57%
1 Month
-43.59%
-43.59%
3 Month
-29.13%
-29.13%
6 Month
-38.00%
-38.00%
1 Year
-11.99%
-11.99%
More News
Read More
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm
January 12, 2021
From
GlobeNewswire News Releases
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
January 12, 2021
From
Business Wire News Releases
SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Fir
January 09, 2021
From
PR Newswire
Noteworthy Wednesday Option Activity: CALX, CCS, SRPT
January 20, 2021
Tags
Stocks
From
Market News Video
Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine?
January 22, 2021
From
Investor's Business Daily
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
January 08, 2021
From
Business Wire News Releases
NASDAQ:SRPT Shareholder Notice: Investigation over Potential Securities Laws Violations by Sarepta Therapeutics, Inc.
January 18, 2021
From
SBWire - Latest Press Releases
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
January 09, 2021
Tags
AZN
Market News
Top Stories
From
Benzinga
Here's Why Sarepta Therapeutics Lost Support on Wall Street
January 10, 2021
Tags
JPM
RHHBY
SRPT
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.